Latest news and insights on the pharmaceutical industry | Indian Pharma Post

Results For "Shukui-Qin"

1 News Found

Imfinzi plus chemotherapy approved in China as for metastatic biliary tract cancer
Drug Approval | November 16, 2023

Imfinzi plus chemotherapy approved in China as for metastatic biliary tract cancer

Approval based on results from TOPAZ-1 global Phase III trial and a Chinese patient